Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584402 · ClinicalTrials.gov registry record · NA
Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00584402 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 8 participants.
The verdict
NCT00584402, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of the Definity (perflutren lipid microsphere Injectable Suspension) ultrasound contrast agent in identifying small tumors (hepatomas \& metastases) within the liver. Primary objective: To estimate the increase in conspicuity of small intrahepatic tumors with contrast-enhanced sonography Secondary Objectives: To estimate the effect of tumor type, size, location and depth on the conspicuity of small tumors on contrast-enhanced sonography
Interventions
- DRUG perflutren lipid microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584402
The ClinicalTrials.gov registry entry for NCT00584402 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which perflutren lipid microspheres is the first listed.
NCT00584402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584402 about?
NCT00584402 is a clinical study titled "Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation". The purpose of this study is to determine the efficacy of the Definity (perflutren lipid microsphere Injectable Suspension) ultrasound contrast agent in identifying small tumors (hepatomas \& metastases) within the liver. Primary objective: To estimate the increase in conspicuity of small intrahepa...
What is the current status of trial NCT00584402?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2007-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00584402?
The interventions under investigation include: perflutren lipid microspheres (DRUG).
Who is sponsoring clinical trial NCT00584402?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.